DatasetName,SCAF4_S(1139) SCAF4_S(1141) SCAF4_S(216) SCAF4_S(312) SCAF4_S(982) SCAF4_T(2) SCAF4_T(235),SCAF4_M(149) SCAF4_M(154) SCAF4_S(1004) SCAF4_S(1037) SCAF4_S(154) SCAF4_S(429) SCAF4_S(635) SCAF4_S(656) SCAF4_T(149) SCAF4_T(236) SCAF4_T(237) SCAF4_T(652)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,0.5348110139423546
FSO2013_Ratio M/L normalized Rep3,,0.5421502680678025
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.5454888695458114
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5379172041837016
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,0.5380874662237688
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5328276498858149
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.5353469977676536
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.5512842594134258
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.539410766578295
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.43281773992599765,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,0.5355361890386646
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.5431624901317559
RB2022_5_PreEndurance,,0.5328638882938654
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,0.5365276252292642
EP2017_Untreated R#4 normalized log2 ratio,,
WZ2023_Pu_010_30min,,0.527497928322089
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,0.5341153302130839
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5359128408509711
RB2022_8_RecoveryEndurance,,0.530737506725071
KBE2022_Log2_Ex_14_U,,0.5443011493558386
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.5479673942449719
JJ2018_Ratio H/L normalized___1,,0.5296127842070739
ZQ2022_C2,,
RB2022_5_PreSprint,,0.5312685265598385
PG2020_Intensity 8h_C,,0.543594020292125
AH2018_SILAC_MR_2_N,,0.5317637994414323
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.5255381557943132
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,0.534286237317127
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,0.5315595584961832
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,0.534937506664097
GF2025_P6_Sph,0.4389361679841754,0.5341285779486566
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5328181379275813
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,0.5275383220174089
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.4321759220905868,
KBE2022_Log2_Ex_34_U,,0.5368317927313103
WZ2023_Pu_005_10min,,0.5276389887330409
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.5300896686430514
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,,0.5334062940167591
AH2018_SILAC_MR_2_X,,0.5361478947792487
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.5412072098081323
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,0.5300503854465548
EJN2021_3_Rest_Basal,,0.5389913385671019
CR2017_Ratio Replicate 1.3,,0.5330754573835113
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,0.5344607013335688
AH2018_SILAC_M_2_N,,0.5337555670254523
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5278573481519325
AH2018_LFQ_1_C,,0.5337020497875717
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.5421460744402308
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,0.5318228935972905
CK2022_11 40-1,,0.5291200138693611
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.5321271582165356
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.530148873307381
FSO2013_Ratio H/L normalized Rep2,,0.5416364039992383
WZ2023_Pu_005_20min,,0.5310739060426212
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.5298109870798774
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,0.5373242470121277
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5359082936844622
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.5426900550046728
CK2022_1 200-1,0.43356351226918843,0.5447268013415648
PG2020_Intensity Mock_10h_D,,0.5309065241113154
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,0.5316806519787326
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.5462650197472012
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.5324339021783883
KBE2022_Log2_Ex_8_T,,0.5426923365636793
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.5306766648341191
CK2022_3 40-1,,0.5298566447844245
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,0.5420097220092225
HH2022_Reporter intensity 8,0.42304716524467345,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.532966160899382
EJN2021_5_Rest_Basal,,0.5358411433012586
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,0.5462257365480231
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,0.5300691784265572
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.5331357192975202
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.5380983399740088
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.43962210603404855,0.533220981023371
HS2024_8_I_T3,,
CF2017_EOC 3,,0.547957038046749
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,0.5347890582600056
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.5305201915768736
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.5443521724393544
KS2014_Intensity N3,,0.5395746035655731
RB2022_4_RecoveryEndurance,,0.5302371970491196
RB2022_5_RecoveryEndurance,,0.5294419415000429
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.536064742127806
FSO2013_Ratio H/M normalized Rep2,,0.5390000902138343
RAM2015_Log2 A,,0.5327680367065329
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,0.530751995527628
CF2017_OSE 27,,0.5457004775136381
KS2014_Intensity E15_2,,0.5425744877022108
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.5454625984690362
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.541810514633542
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.5341178862639898
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,0.5158282321379825
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.43335887079564533,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,0.5478273702527922
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.4426449631663379,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.5315479266785013
AH2018_SILAC_IT_3_X,,0.5291426360227767
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.5176364507633975
FSO2013_Ratio M/L normalized Rep2,,0.5375492402145395
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.42772761591430614,0.5330462554743972
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.5300616716508736
RB2022_6_PreSprint,,0.529601138709726
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.5233597735515652
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.532484406662332
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5390704842452915
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.528754814909996
EJN2021_4_Rest_Ins,,0.5417010573964248
RN2012_H05,,0.5416937692058802
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5440221604008673
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,0.5321742097708947
EJN2021_1_Rest_Ins,,0.5409447334817998
HH2022_Reporter intensity 3,0.4391865245629291,0.5412796830937832
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.5392551139034946
JW2021_After_3,,
GF2025_P8_Sph,0.45713633281261046,0.5287393093106874
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,0.5337864687985568
AH2018_SILAC_2_N,,0.5328890060516301
CK2022_11 200-1,0.4310286718955683,0.5491801559380074
CK2022_12 200-1,0.4300752269209198,0.5508199124341103
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.42770212443820943,0.5333371930858116
WZ2023_Su_010_20min,,0.523492721913422
AH2018_TMTMS2_2_N,,0.5485240683537532
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.5350417920337591
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.4208520218764137,
AH2018_TMTMS3_Pool,,0.5341374506389733
KS2014_Intensity N4,,0.5437146955541992
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.551083208933644
CK2022_14 200-1,0.43048885956343985,0.5522848811474953
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,0.5293255238601479
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.5351973681600944
AST2020_anti-CD3+PDL2.2,0.43437322920594484,
PG2020_Intensity Mock_10h_A,,0.5172040139632228
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.538578982929583
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.5439563151877137
GF2025_P1_Adh,,0.5253016890799364
GF2025_P1_Sph,,0.5463178829567344
EJN2021_5_Ex_Basal,,0.5367821606445055
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,0.5370960854837102
CF2017_EOC 1,,0.5468637056482928
CK2022_3 200-1,0.43343839375226023,0.5438563428073973
AH2018_LFQ_IT_3_C,,0.5332194424634694
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,0.5333966665050566
RB2022_3_RecoverySprint,,0.5312278156734641
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,0.5284302950061376
CK2022_2 40-1,,0.5295640327688974
RB2022_1_PostSprint,,
CK2022_4 200-1,0.4364555935924604,0.5444740770691235
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.5441715845366266
AR2021_ALG 1 μM,,0.5313464990438442
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.5389287074613
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.5424745167450923
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.4374433912698815,0.5393932522774226
CK2022_9 16-1,,0.5434109098278843
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.4311414457362967,0.5528081137290589
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.5303411537763892
CK2022_16 16-1,,0.5451035066847784
FS2019_db/db3,,
CK2022_15 40-1,,0.5293191401792525
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.5214276713804938
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.5358456496454892
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.5320852951977664
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.5317325450595507
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.5429652039094033
AH2018_LFQ_M_1_N,,0.5378473809681981
KBE2022_Log2_Ex_27_U,,0.5465752889657184
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.538673540071594
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,0.5255236062306564
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,0.533323856405124
YA2020_Reporter_intensity_Normal_No.4,,0.5410145365099954
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.5292226456081903
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.5438448734616835
RN2012_L13,,0.5263718015287063
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.5422602856815577
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5401701134570068
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.529884717474957
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.533887363498116
HH2022_Reporter intensity 6,,0.5317312163088006
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5350731974709994
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.548025678883883
GF2025_P3_Adh,,0.5310217914995777
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.5473693770391931
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.5452199050059494
KBE2022_Log2_Ex_19_U,,0.5463902804353644
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,0.536057440799953
RB2022_4_PostStrength,,0.5327291191298763
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,0.4324378045723195,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,0.5369202966193724
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5375203093217846
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,0.5387720004875287
RB2022_7_RecoverySprint,,0.5307719387660599
YA2020_Reporter_intensity_Normal_No.3,,0.5469109004406498
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.530744668500064
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.42686583838293235,0.5278868375115009
HH2022_Reporter intensity 1,0.43912909788019455,0.5410763958884429
HH2022_Reporter intensity 2,0.4402683131646846,0.541174882452374
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.5384404710713143
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,0.5313519959688475
CR2017_Ratio Replicate 2,,0.5378575483998712
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.5412665127646561
AR2021_KD 72h,0.4270346007071111,0.5348607596070309
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.5452157700967111
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.5340232448655142
KBE2022_Log2_Ex_9_U,,0.5431182067605964
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,,0.5447058484870844
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.5130210010853767
CF2017_OSE 29,,0.5467064239580249
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5377567837351199
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,0.5344998926628691
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.531399859489419
RB2022_7_RecoveryEndurance,,0.5352622030865287
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.5397824503971203
TM2022_S2.12h.B,,
RN2012_L15,,0.544555325411525
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.524965481484014
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,0.544105810640939
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.42957871398340053,0.5410700101383547
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.4371090748686499,0.5464361126769968
CK2022_5 200-1,0.4362753772516414,0.545367741464645
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,0.5370262054259746
FSO2013_Ratio H/L normalized Rep2___1,,0.5417913956380561
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,0.5292426907109031
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.5377028158819311
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,,0.5391837925301949
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5367396716224092
CK2022_4 16-1,,0.5445244308821997
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.5357967500987767
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.5355021905636795
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,0.5337609376210725
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.542589740304355
FSO2013_Ratio H/L normalized Rep3,,0.5572366609442143
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,0.533341032965823
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,0.5460925897927025
AH2018_SILAC_IT_2_N,,0.5279886784192253
AH2018_SILAC_IT_1_X,,0.5293897755762608
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.4433989647900626,0.5367166652278886
WZ2023_Pe_025_20min,,0.5183417299689662
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.5338281094196106
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,0.5485865470213886
RN2012_H06,,0.541010888129205
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,,0.5187749826460059
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5358873305349615
WZ2023_Su_025_10min,,0.5087295225978848
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,0.530416410301319
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.5240666555621294
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,0.5335768747051032
KS2014_Intensity,0.4139374564140863,0.5392041061001251
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.5417084587813233
LY2019_P7+,,0.5276541862180367
EP2017_Untreated R#1 normalized log2 ratio,,
RN2012_L10,,
PG2020_Intensity 4h_C,,0.5198663491987985
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.5432475946451939
RB2022_8_PostStrength,,0.536875985252722
AH2018_SILAC_IT_2_X,,0.5285137717971562
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,0.5306092739757834
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,0.543102518708495
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.5377986845902029
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,0.5380493293804657
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.4308674889214571,0.5540528310431981
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,0.4608203539875788,0.5368206037325387
CK2022_6 200-1,0.43742755680003864,0.5463086986441575
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.5352590821597009
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.5158865110667675
EP2017_Untreated R#3 normalized log2 ratio,,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.4362552042372263,0.5447320671850309
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.5332723057624734
RB2022_7_PostEndurance,,0.5252771575005557
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,0.5406515097671856
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,0.5364884176984606
AH2018_SILAC_2_C,,0.5332536199611021
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,0.5462473620710492
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.5418266693626005
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.5275826936082272
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.5405125464972743
PG2020_Intensity CT_C,,0.49520578344827443
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,0.5432649865373395
EP2017_Untreated R#3 log2 ratio,,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.5383937598790048
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,0.5266687810064291
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,0.5388474019955473
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.5457598205770834
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,0.5315163042352494
CR2017_Ratio Replicate 2.3,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5230966083334286
YA2020_Reporter_intensity_Normal_No.2,,0.5480949023510323
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.5405312766160008
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5374619829245092
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.5448101359848908
CK2022_2 16-1,,0.542479229913665
RAM2015_Log2 B,,0.5371957794784953
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.5417644338476678
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,0.5372885166286837
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.5066801529896512
WZ2023_Su_025_30min,,0.5235394224504446
AH2018_LFQ_4_N,,0.5292896542516629
CR2017_Ratio Replicate 1.2,,0.5304881969720153
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,0.5287968288298578
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.42884688331474907,0.5270105775097229
AH2018_SILAC_M_1_X,,0.5385838436555624
RB2022_7_PreEndurance,,0.5364911767178213
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5351432858920666
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.44207729235774035,0.5503204286974357
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,0.5349850738833085
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5343813939581914
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,0.5275139400786303
KS2014_Intensity C5,0.39309657489440347,0.5412598503913687
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,0.5270480166409339
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.4451781097154041,0.5623233146588226
RB2022_3_PostStrength,,0.5273803194769376
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.5332233611517875
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.5469384203757035
AH2018_LFQ_2_X,,0.529551680520817
PG2020_Intensity 2h_B,,0.5145673196612736
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,0.5364278968437027
KS2014_Intensity E15_3,,0.5423563388438892
GF2025_P3_Sph,,0.5460785808580519
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.5379127760933934
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.4285565619577257,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5283016172138738
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,0.5275513552099234
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.5264325572705832
ZQ2022_N1,,
LY2019_P6-,,0.5347928271133447
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5394604363095935
AH2018_LFQ_3_N,,0.5290441540530973
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,0.5431558872018581
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,0.5385201094549036
JJ2018_Ratio H/L normalized pP3,,0.5316040700319419
CK2022_7 40-1,,0.531599095838999
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.5294280474471191
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,0.529738595476336
RB2022_5_PostEndurance,,0.5242819909479035
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,,0.5115605483867619
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.5377051773441007
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,0.5365668400729404
FSO2013_Ratio H/L normalized Rep1,,0.5251296731788199
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,0.536460286760387
CK2022_13 40-1,,0.5299964628984852
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,0.5273086517981012
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,0.5387451714219383
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.5429007945357379
EP2017_Pervanadate R#3 log2 ratio,,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,0.5367751460108211
AH2018_SILAC_MR_3_C,,0.5328786508544592
AH2018_LFQ_M_4_C,,0.535061872264284
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,0.5334770053544879
RN2012_H04,,0.530635304989679
CK2022_6 40-1,,0.5307815763346336
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.5456352614994615
LY2019_P3-,,0.5487092824640944
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,0.5378518435654182
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,0.5331566213586519
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.5398208714191634
AST2020_Control.1,0.43229387116814955,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.5160209942030308
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,0.5181502693558175
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.42861469981675027,0.5359168284132628
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.5478807524747998
RB2022_4_PreSprint,,0.5317157531894632
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5327019733321703
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,0.5315286619862517
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5397719855804879
LY2019_P8+,,0.5331706824817356
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,0.5381319525941541
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.5272973028336625
KS2014_Intensity pY_PV1,,0.5409941546425124
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.42927305397530413,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.537735954223459
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.5434327456561809
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.553174490763106
LY2019_P2-,,0.5448039226923558
AH2018_LFQ_IT_1_X,,0.5372376887076686
JJ2018_Ratio H/L normalized pP3___1,,0.5315261137848237
RB2022_8_RecoveryStrength,,0.5243627767715137
WZ2023_Pe_005_20min,,0.5316388791464759
AST2020_Control.2,0.43483830084884495,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.5310384152667986
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,0.5462460129062446
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.5405365675484008
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.5406113274689922
AH2018_TMTMS3_3_N,,0.5325669803155821
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.531175181411217
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,,0.5431118154565385
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,0.5273998854012109
KS2014_Intensity C2,0.4256915408693172,0.543143944278092
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,0.5402344527119854
CK2022_9 200-1,0.43289949354200447,0.5483464529580336
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.43298853892635153,0.5483631755823756
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,0.5295043873843092
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.5301689310818426
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,0.5347338173043218
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.5354613044770757
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,0.5378280382924764
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.5415064214123381
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,0.5249930940406994
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,,0.530616514357359
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.5440812503116448
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,0.537353159827635
JJ2018_Ratio H/M normalized pP3,,0.5373551665257418
AH2018_SILAC_MR_2_C,,0.5277496144813641
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5273338768057453
JJ2018_Ratio H/M normalized___1,,0.5360054813817613
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.43962901856478476,0.5358300455826158
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,0.5265568373573123
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.43462984805871663,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,0.5321534114303971
KBE2022_Log2_Ex_29_U,,0.5443606010429475
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.5323848319307561
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.43045629724103496,0.5530428095970447
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,0.536116596275335
JJ2018_Ratio M/L normalized pP3___1,,0.5345245852772804
KBE2022_Log2_Ex_34_T,,0.53691043327363
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,0.5382496149574895
LY2019_P2+,,0.5277195508368497
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.4328382186566285,0.5439991714971726
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,0.5223035879314589
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.5389173160034909
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.5444318439625803
KBE2022_Log2_Ex_44_U,,0.5403012082879725
WZ2023_Pe_010_20min,,0.5370671424676735
KS2014_Intensity pY_C6,,0.5460107797705512
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,0.532019905504976
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.42454373474821167,0.5434605876659218
FSO2013_Ratio H/M normalized Rep3___1,,0.5412855264980785
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5338773476080821
AH2018_SILAC_M_2_X,,0.5322974589200248
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.5430858635995124
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,0.522512035775493
PG2020_Intensity 6h_C,,0.5306963033650945
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5325983655285313
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.5495888118513933
CK2022_15 16-1,,0.5439842345620383
CK2022_3 16-1,,0.5429138417459762
LY2019_P4-,,0.5408500190588491
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.44244168728148864,0.540532099916624
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5449493634072317
CK2022_10 16-1,,0.5432808902761233
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.4453324472039581,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,,0.5355856414533352
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,0.5421292565957644
CF2017_FTE 16,,0.5395783751057983
AR2021_L41 10 μM,,0.54952134402265
CF2017_EOC 2,,0.5474135717887374
RB2022_6_PostEndurance,,0.5283536388938889
AH2018_SILAC_1_N,,0.5360778968900021
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,0.5274504165310133
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.545410079349671
ZX2022_CB treated Replicate 1,,0.5324027448799719
BS2014_Log2(Ratio H/L normalized Rep_3),,0.529313708566378
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.4407467525678368,0.5413239661204362
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.5487585605073881
AR2021_L41 1 μM,,0.5459823343324686
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.5475568190969902
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.5320185485606521
KS2014_Intensity C4,0.44404564957077186,0.5445167442346427
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.5521274761543459
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5352692794068857
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,0.5392714659407044
YA2020_Reporter_intensity_Cancer_No.2,,0.5360109801665266
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,0.5260627520029578
AH2018_SILAC_IT_3_C,,0.5342179376707243
WZ2023_Pu_025_10min,,0.5301214375706339
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,0.5418958444686158
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.5495363602677901
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,0.5284793754165742
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5328405584413497
KS2014_Intensity C6,0.4065439585341984,0.530519865950988
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.5292341602346661
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5337699982987213
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.5298624045641975
AH2018_SILAC_IT_2_C,,0.5352747599469735
CK2022_5 40-1,,0.531115148760467
AH2018_LFQ_3_X,,
UK2020_UA_3,,
LY2019_P7-,,0.5370813451002585
GF2025_P5_Adh,,0.5370964392827973
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.557695904129467
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.5439680097837463
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,0.5404621134852342
PG2020_Intensity CT_B,,0.5304416774577959
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.5292399629836776
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.5318560550032149
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5350311361280023
YA2020_Reporter_intensity_Cancer_No.4,,0.5408037495192941
KS2014_Intensity pY_E5_2,,0.5432769668600078
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.5632565591380486
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,0.5373586099341987
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,0.533275731658773
FR2021_Intensity.H,,
CK2022_14 16-1,,0.5444388305626825
AST2020_anti-CD3+PDL2,0.4330607000573261,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.5412456797478831
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,
AH2018_TMTMS2_1_X,,0.5486269497769681
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.540594953823483
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.5498243872286687
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.5372289520252067
PG2020_Intensity 10h_B,,0.5170102663393038
AH2018_TMTMS3_1_X,,0.5344534733245573
CF2017_FTE 14,,0.5427202181752493
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.5459555325192355
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,0.5409966712848218
EP2017_Untreated R#2 normalized log2 ratio,,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5219114827383627
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,
AS2011_Ratio H/L Normalized RNAi_2_1,,
